1,427 followers
RT @FrontBioeng: New Research: Use of the Reversible Myogenic to Lipogenic Transdifferentiation Switch for the Design of Pre-clinical Drug…
RT @FrontBioeng: New Research: Use of the Reversible Myogenic to Lipogenic Transdifferentiation Switch for the Design of Pre-clinical Drug…
RT @FrontBioeng: New Research: Use of the Reversible Myogenic to Lipogenic Transdifferentiation Switch for the Design of Pre-clinical Drug…
New Research: Use of the Reversible Myogenic to Lipogenic Transdifferentiation Switch for the Design of Pre-clinical Drug Screening in Idiopathic Pulmonary Fibrosis: Idiopathic Pulmonary Fibrosis (IPF) is an end-stage lung… https://t.co/aA3B07qqP8 #bioengi